Login to Your Account


AbbVie Splits from Abbott; Humira Is a Top Priority

By Marie Powers
Staff Writer

Wednesday, January 2, 2013

AbbVie Inc. launched Wednesday as an independent biopharma, splitting from Abbott in a plan initially disclosed in October 2011. AbbVie took several dozen marketed products and a portfolio of late-stage compounds in immunology, neuroscience and oncology.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription